Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002007919-24-000040
Filing Date
2024-08-26
Accepted
2024-08-26 16:26:53
Documents
1
Period of Report
2024-08-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1724704006.html 4  
1 FORM 4 wk-form4_1724704006.xml 4 6089
  Complete submission text file 0002007919-24-000040.txt   7623
Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address
FORSYTH DOUGLAS (Reporting) CIK: 0001240801 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42031 | Film No.: 241241717

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)